Jiangsu Hengrui Medicine Co., Ltd.
600276
Clasificación en acciones
#548
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Precio por acción
$6.89
Capitalización bursátil
$43.94B
Cambio (1 día)
-2.91%
Cambio (1 año)
-24.78%
País
CN
Comercio Jiangsu Hengrui Medicine Co., Ltd. (600276)
Categoría
Healthcare
Historial del precio de la acción de Jiangsu Hengrui Medicine Co., Ltd. (600276)
Precio más alto de cierre: $6.77 el 2026-10-01
Precio más bajo de cierre: $0.04 el 2005-07-01
Precio más bajo de cierre: $0.04 el 2005-07-01
Historial del precio de la acción de Jiangsu Hengrui Medicine Co., Ltd. desde 2005 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -9.37% |
| 2025 | 33.70% |
| 2024 | 2.96% |
| 2023 | 15.17% |
| 2022 | -30.24% |
| 2021 | -37.82% |
| 2020 | 50.21% |
| 2019 | 73.88% |
| 2018 | 25.89% |
| 2017 | 85.51% |
| 2016 | 3.95% |
| 2015 | 100.95% |
| 2014 | 12.39% |
| 2013 | 42.52% |
| 2012 | 4.92% |
| 2011 | -16.03% |
| 2010 | 40.18% |
| 2009 | 61.62% |
| 2008 | -8.70% |
| 2007 | 153.91% |
| 2006 | 239.46% |
| 2005 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
